Clinical Trial Update: Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing tadalafil on exercise capacity in pediatric Fontan patients with single-ventricle physiology has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fontan Circulation
• Single-ventricle Congenital Heart Disease

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: University of Utah | Conditions: Single Ventricle | Phase 1 | Status: COMPLETED